InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Bornstein Jeffrey S, Director. Director active across 3 companies, notably Allovir, Inc.. In total, 15 disclosures have been recorded. Split: 3 buys · 5 sells. Total volume traded: €819k. History available since 10 February 2022. The latest transaction was filed on 21 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Bornstein Jeffrey S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
9,558 shares@ US$5.48Common StockSEC:0001628280-26-053904:0
32,328 shares@ US$15.0555.1% of flowCommon StockSEC:0001628280-25-055931:0
105,263 shares0Common StockSEC:0001805077-25-000071:0
132,720 shares@ US$2.6392.4% of flowCommon StockSEC:0001805077-24-000104:0
35,000 shares0Common StockSEC:0000950170-24-070598:0
32,328 shares0Common StockSEC:0001805077-24-000044:0
52,601 shares0Common StockSEC:0001628280-23-018764:0
35,000 shares0Common StockSEC:0001209191-23-029103:0
20,000 shares@ US$1.29687.6% of flowCommon StockSEC:0000950103-22-019549:0
Canonical exit: 8 Feb 2023 (T+90)
5,000 shares@ US$4.639321.9% of flowCommon StockSEC:0000899243-22-015826:0
Canonical exit: 25 Jul 2022 (T+90)
5,000 shares@ US$8.8764.1% of flowCommon StockSEC:0000899243-22-005623:0
Canonical exit: 11 May 2022 (T+90)
50,000 sharesCommon StockSEC:0001231205-16-000111:0
40,000 sharesCommon StockSEC:0001231205-16-000111:1
125,000 sharesCommon StockSEC:0001231205-16-000111:2
78,313 sharesCommon StockSEC:0001231205-16-000111:3
15 of 15 declarations
About Bornstein Jeffrey S
Jeffrey S. Bornstein is Administrateur and has 14 filings in total. Across the 14 sampled filings, the period runs from 2016-02-05 to 2025-12-08, with EUR 86509 of buys and EUR 732977 of sells, mainly in Eos Energy Enterprises, Inc. and Allovir, Inc., and the most frequent transaction nature is Cession.
